Evaluation of ultrasmall superparamagnetic iron oxide-enhanced MRI of carotid atherosclerosis to assess risk of cerebrovascular and cardiovascular events: follow-up of the ATHEROMA trial

Cerebrovasc Dis. 2012;34(2):169-73. doi: 10.1159/000339984. Epub 2012 Aug 22.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Atorvastatin
  • Carotid Artery Diseases / diagnosis*
  • Carotid Artery Diseases / epidemiology
  • Contrast Media* / pharmacokinetics
  • Dextrans* / pharmacokinetics
  • Diabetes Complications / epidemiology
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / pathology
  • Female
  • Follow-Up Studies
  • Heptanoic Acids / administration & dosage
  • Heptanoic Acids / pharmacology
  • Heptanoic Acids / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Kaplan-Meier Estimate
  • Macrophage Activation / drug effects
  • Macrophages / pathology
  • Magnetic Resonance Imaging / methods*
  • Magnetite Nanoparticles*
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Proportional Hazards Models
  • Pyrroles / administration & dosage
  • Pyrroles / pharmacology
  • Pyrroles / therapeutic use
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Stroke / epidemiology*
  • Stroke / etiology

Substances

  • Contrast Media
  • Dextrans
  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Magnetite Nanoparticles
  • Pyrroles
  • ferumoxtran-10
  • Atorvastatin